Ten-year experience of rhinocerebral zygomycosis in a teaching hospital in Tehran

Iranian Journal of Clinical Infectious Diseases

Volumn 5, Issue 3, 2010, Pages 117-120

  Barati, Mitra ^a   Talebi Taher, Mahshid ^a   Nojomi, Marzieh ^a   Kerami, Fatemeh ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Prognosis; Rhinocerebral zygomycosis; Treatment

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEBRIDEMENT; DIABETES MELLITUS; FEMALE; HUMAN; IRAN; MALE; MEDICAL RECORD REVIEW; MORTALITY; RETROSPECTIVE STUDY; RHINOCEREBRAL ZYGOMYCOSIS; SEX DIFFERENCE; SURVIVAL RATE; TEACHING HOSPITAL; TREATMENT OUTCOME; VISUAL IMPAIRMENT; ZYGOMYCOSIS;

EID: 84857078266     PISSN: 17355109     EISSN: 20081081     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jung SH, Kim SW, Park CS, Song CE, Cho JH, Lee JH, et al. Rhinocerebral mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx. 2009;36(3):274-9.
2. Petrikkos G, Skiada A, Sambatakou H, Toskas A, Vaiopoulos G, Giannopoulo M, et al. Mucormycosis: Ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis. 2003;22:753-56.
3. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):236-301.
4. Bisdas S, Lenarz M, Becker H. Rhinocerebral mucormycosis. Klin Neuroradiol. 2003; 13:213-7.
5. Jindal S, Kulkarni S, Sheikh S, Chandar VV, Bhatnagar D, Aggarwal A. Invasive rhinocerebral mucormycosis: a case report with a review of the literature. Oral Radiol. 2008;24:42-48.
6. Spellberg B, Edwards J Jr, Ibrahim A. Novel prospect on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556-69.
7. Khor BS, Lee MH, Leu HS, Liu JW. Rhinocerbral mucormycosis in Taiwan. J Microbiol Immun Infect. 2003;36(4):266-69.
8. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerbral mucormycosis: major review. Surv Ophthalmol. 1994;39:3-22.
9. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis. 2005;41:634-53.
10. Bhansali A, Bhadada S, Sharm A, Suresh V, Gupta A, Singh P, et al. Presentation and outcome of rhinoorbital- cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80:670-74.
11. Sims CR, Zeichner LO. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res. 2007;38:90-3.
12. Thajeb P, Thajeb T, Dai D. Fatal strokes in patients with rhino-orbito- cerebral mucormycosis and associated vasculopathy. Scand J Infect Dis. 2004;36:643-48.
13. Epstein VA, Kern RC. Invasive fungal sinusitis and complications of rhinosinusitis. Otolaryngol Clin North Am. 2008;41:497-524.
14. Odessey E, Cohn A, Beaman K, Schechter L. Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation. Surg Infect (Larchmt). 2008;9(1):91-8.